Sabang, Rosita T.
HRN: 04-74-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/20/2024
12/27/2024
IV
4.5gm
Q6h
CELLULUTIS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes